Metaplanet Adds 1,234 BTC, Total Holdings Hit 12,345 in Treasury Strategy Push
Metaplanet has expanded its Bitcoin reserves with the acquisition of an additional 1,234 BTC, bringing its total holdings to 12,345 Bitcoin.
Metaplanet has expanded its Bitcoin reserves with the acquisition of an additional 1,234 BTC, bringing its total holdings to 12,345 Bitcoin.
The purchase, disclosed in a regulatory filing on Thursday, underscores the Japanese firm’s deepening commitment to establishing Bitcoin as a central pillar of its corporate treasury strategy.
*Metaplanet Acquires Additional 1,234 $BTC , Total Holdings Reach 12,345 BTC* pic.twitter.com/ppeGIrfVfe
— Metaplanet Inc. (@Metaplanet_JP) June 26, 2025
This latest investment builds on the momentum generated by the company’s ambitious “555 Million Plan”—a large-scale initiative aiming to raise $5.4 billion to acquire 210,000 BTC by 2027. If successful, this would give Metaplanet control of roughly 1% of Bitcoin’s fixed 21 million supply, solidifying its reputation as one of the most aggressive institutional adopters of digital assets in Asia.
Fueling this expansion, Metaplanet announced on June 24 that it had raised more than $517 million on the first day of the plan. The funds were generated through the issuance of 54 million shares, exercised by EVO Fund under a pre-existing stock acquisition rights agreement. This early influx of capital gave the company the financial momentum needed to move forward with its latest Bitcoin acquisition.
According to Thursday’s filing, the newly purchased BTC was acquired at an average price of ¥15,617,281 per coin—approximately $107,900. This significant purchase reflects the firm’s ongoing confidence in Bitcoin’s long-term value and its role within Metaplanet’s financial infrastructure.
The company has confirmed that 96% of all funds raised under the 555 Million Plan will be allocated directly to Bitcoin purchases. The remaining 4% will be directed toward bond redemptions and structured yield-generating strategies, demonstrating a balanced yet Bitcoin-focused financial approach.
In a closely related move, Metaplanet had previously disclosed in a June 23 regulatory filing that it acquired 1,111 BTC, bringing its total holdings at that time to 11,111 BTC. That acquisition cost the company approximately ¥17.26 billion, or around $108 million, further emphasizing the pace and scale of its ongoing crypto investment strategy.
If you want to read more news articles like this, visit DeFi Planet and follow us on Twitter , LinkedIn , Facebook , Instagram , and CoinMarketCap Community.
“Take control of your crypto portfolio with MARKETS PRO, DeFi Planet’s suite of analytics tools.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
